Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Opioid-Related Disorders | 12 | 2023 | 59 | 7.170 |
Why?
|
Stress Disorders, Post-Traumatic | 13 | 2023 | 233 | 3.450 |
Why?
|
Mental Disorders | 12 | 2021 | 181 | 3.270 |
Why?
|
Veterans | 9 | 2022 | 94 | 2.870 |
Why?
|
Analgesics, Opioid | 5 | 2022 | 216 | 2.540 |
Why?
|
Substance-Related Disorders | 8 | 2024 | 96 | 2.300 |
Why?
|
Adolescent | 44 | 2024 | 2324 | 2.290 |
Why?
|
Homeless Youth | 6 | 2022 | 14 | 2.290 |
Why?
|
Alcoholism | 7 | 2022 | 75 | 2.150 |
Why?
|
Electronic Health Records | 8 | 2021 | 75 | 1.990 |
Why?
|
Humans | 89 | 2024 | 28449 | 1.980 |
Why?
|
Mental Health Services | 6 | 2021 | 59 | 1.900 |
Why?
|
Psychiatry | 3 | 2021 | 15 | 1.830 |
Why?
|
Prescription Drug Misuse | 3 | 2019 | 6 | 1.830 |
Why?
|
Buprenorphine | 2 | 2023 | 6 | 1.620 |
Why?
|
Machine Learning | 7 | 2021 | 71 | 1.540 |
Why?
|
Depressive Disorder | 4 | 2019 | 185 | 1.520 |
Why?
|
Primary Health Care | 4 | 2020 | 98 | 1.520 |
Why?
|
Antipsychotic Agents | 5 | 2021 | 65 | 1.510 |
Why?
|
Prisoners | 6 | 2013 | 13 | 1.430 |
Why?
|
Research Design | 4 | 2022 | 208 | 1.380 |
Why?
|
Juvenile Delinquency | 8 | 2011 | 16 | 1.380 |
Why?
|
Inpatients | 4 | 2020 | 149 | 1.350 |
Why?
|
United States | 19 | 2024 | 2185 | 1.330 |
Why?
|
Young Adult | 20 | 2021 | 2103 | 1.290 |
Why?
|
Gender Identity | 2 | 2021 | 22 | 1.270 |
Why?
|
Aggression | 5 | 2018 | 32 | 1.240 |
Why?
|
Female | 51 | 2024 | 15777 | 1.230 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 3 | 2021 | 37 | 1.180 |
Why?
|
Child | 18 | 2022 | 1424 | 1.170 |
Why?
|
Male | 48 | 2024 | 15352 | 1.150 |
Why?
|
Referral and Consultation | 4 | 2022 | 91 | 1.140 |
Why?
|
Adult | 28 | 2022 | 8155 | 1.100 |
Why?
|
Child Psychiatry | 3 | 2018 | 11 | 1.070 |
Why?
|
Natural Language Processing | 6 | 2021 | 8 | 1.060 |
Why?
|
Transgender Persons | 3 | 2021 | 21 | 1.030 |
Why?
|
Behavior, Addictive | 2 | 2023 | 9 | 1.020 |
Why?
|
Nurse Practitioners | 2 | 2018 | 109 | 0.980 |
Why?
|
Foster Home Care | 2 | 2017 | 4 | 0.970 |
Why?
|
Health Services Accessibility | 4 | 2022 | 113 | 0.960 |
Why?
|
Patient Discharge | 3 | 2021 | 162 | 0.950 |
Why?
|
Delphi Technique | 2 | 2022 | 27 | 0.930 |
Why?
|
Consensus | 2 | 2022 | 98 | 0.890 |
Why?
|
Telemedicine | 2 | 2024 | 119 | 0.890 |
Why?
|
Vulnerable Populations | 2 | 2020 | 28 | 0.860 |
Why?
|
Mentoring | 1 | 2023 | 31 | 0.800 |
Why?
|
Cannabis | 1 | 2021 | 9 | 0.760 |
Why?
|
Length of Stay | 2 | 2020 | 329 | 0.760 |
Why?
|
Sexual and Gender Minorities | 2 | 2019 | 25 | 0.750 |
Why?
|
National Institute on Drug Abuse (U.S.) | 1 | 2021 | 1 | 0.740 |
Why?
|
Child Development Disorders, Pervasive | 1 | 2021 | 17 | 0.730 |
Why?
|
Risk-Taking | 3 | 2019 | 36 | 0.720 |
Why?
|
Crime Victims | 2 | 2024 | 33 | 0.680 |
Why?
|
Cultural Diversity | 3 | 2004 | 29 | 0.680 |
Why?
|
Adolescent Psychiatry | 2 | 2018 | 7 | 0.660 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 257 | 0.650 |
Why?
|
Treatment Adherence and Compliance | 1 | 2019 | 6 | 0.650 |
Why?
|
Bullying | 1 | 2019 | 4 | 0.650 |
Why?
|
Patient Acceptance of Health Care | 1 | 2020 | 82 | 0.650 |
Why?
|
Patient Health Questionnaire | 1 | 2019 | 14 | 0.640 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2019 | 25 | 0.630 |
Why?
|
Psychotropic Drugs | 2 | 2017 | 28 | 0.620 |
Why?
|
Depression | 3 | 2019 | 458 | 0.620 |
Why?
|
Opiate Substitution Treatment | 3 | 2023 | 6 | 0.620 |
Why?
|
Community Health Centers | 1 | 2018 | 13 | 0.610 |
Why?
|
Middle Aged | 17 | 2021 | 9316 | 0.600 |
Why?
|
Interprofessional Relations | 1 | 2018 | 43 | 0.590 |
Why?
|
Disclosure | 1 | 2018 | 14 | 0.590 |
Why?
|
Bias | 1 | 2018 | 39 | 0.590 |
Why?
|
Conflict of Interest | 1 | 2018 | 13 | 0.590 |
Why?
|
Evidence-Based Practice | 1 | 2018 | 85 | 0.590 |
Why?
|
Publishing | 1 | 2018 | 39 | 0.570 |
Why?
|
Quality of Life | 1 | 2022 | 663 | 0.570 |
Why?
|
Mental Health | 5 | 2022 | 123 | 0.560 |
Why?
|
HIV Infections | 2 | 2020 | 490 | 0.560 |
Why?
|
Drug Discovery | 1 | 2017 | 15 | 0.560 |
Why?
|
Informed Consent | 1 | 2017 | 22 | 0.550 |
Why?
|
Social Behavior | 1 | 2017 | 72 | 0.550 |
Why?
|
Meaningful Use | 1 | 2016 | 3 | 0.540 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 196 | 0.510 |
Why?
|
Psychology, Adolescent | 3 | 2011 | 9 | 0.510 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 236 | 0.500 |
Why?
|
Adolescent Behavior | 3 | 2014 | 33 | 0.500 |
Why?
|
Social Media | 2 | 2017 | 49 | 0.500 |
Why?
|
Students, Medical | 3 | 2004 | 49 | 0.500 |
Why?
|
Violence | 3 | 2024 | 42 | 0.490 |
Why?
|
Treatment Outcome | 8 | 2022 | 3619 | 0.480 |
Why?
|
Social Support | 2 | 2016 | 216 | 0.480 |
Why?
|
Antisocial Personality Disorder | 2 | 2011 | 8 | 0.460 |
Why?
|
Military Personnel | 3 | 2019 | 40 | 0.440 |
Why?
|
Physicians | 1 | 2015 | 121 | 0.430 |
Why?
|
Education, Medical, Graduate | 3 | 2018 | 77 | 0.430 |
Why?
|
Veterans Health | 1 | 2013 | 2 | 0.430 |
Why?
|
Rape | 1 | 2013 | 6 | 0.420 |
Why?
|
Child, Preschool | 6 | 2021 | 692 | 0.410 |
Why?
|
Attitude of Health Personnel | 2 | 2004 | 157 | 0.410 |
Why?
|
Adolescent Development | 1 | 2012 | 6 | 0.400 |
Why?
|
Valproic Acid | 2 | 2009 | 13 | 0.400 |
Why?
|
Group Processes | 1 | 2012 | 14 | 0.400 |
Why?
|
Minority Groups | 2 | 2024 | 87 | 0.390 |
Why?
|
Sexually Transmitted Diseases | 1 | 2012 | 17 | 0.390 |
Why?
|
Family Therapy | 1 | 2011 | 2 | 0.390 |
Why?
|
Systems Theory | 1 | 2011 | 3 | 0.390 |
Why?
|
Chicago | 4 | 2019 | 912 | 0.390 |
Why?
|
Refugees | 4 | 2014 | 25 | 0.390 |
Why?
|
Ambulatory Care Facilities | 3 | 2021 | 40 | 0.390 |
Why?
|
Stress, Psychological | 2 | 2018 | 245 | 0.380 |
Why?
|
Teaching | 3 | 2010 | 61 | 0.370 |
Why?
|
Central Nervous System Stimulants | 2 | 2016 | 41 | 0.360 |
Why?
|
Ethnopsychology | 1 | 2010 | 1 | 0.360 |
Why?
|
Urban Population | 1 | 2011 | 159 | 0.360 |
Why?
|
Cultural Competency | 1 | 2010 | 13 | 0.350 |
Why?
|
Retrospective Studies | 6 | 2022 | 3615 | 0.350 |
Why?
|
Housing | 2 | 2021 | 19 | 0.350 |
Why?
|
Models, Educational | 1 | 2010 | 35 | 0.350 |
Why?
|
Surveys and Questionnaires | 10 | 2021 | 1215 | 0.330 |
Why?
|
Morals | 2 | 2020 | 14 | 0.330 |
Why?
|
Criminal Psychology | 1 | 2009 | 1 | 0.320 |
Why?
|
Criminals | 1 | 2009 | 1 | 0.320 |
Why?
|
Aged | 9 | 2021 | 9320 | 0.320 |
Why?
|
Crime | 1 | 2009 | 7 | 0.320 |
Why?
|
Temperament | 1 | 2009 | 13 | 0.320 |
Why?
|
Impulsive Behavior | 1 | 2009 | 15 | 0.320 |
Why?
|
Patient Readmission | 2 | 2020 | 133 | 0.310 |
Why?
|
Anxiety Disorders | 2 | 2021 | 171 | 0.310 |
Why?
|
Curriculum | 3 | 2004 | 150 | 0.310 |
Why?
|
Sexual Behavior | 2 | 2021 | 57 | 0.310 |
Why?
|
Character | 1 | 2008 | 3 | 0.310 |
Why?
|
Mass Screening | 2 | 2020 | 185 | 0.300 |
Why?
|
Sex Offenses | 2 | 2018 | 25 | 0.300 |
Why?
|
Infant, Newborn | 2 | 2021 | 656 | 0.300 |
Why?
|
Mobile Applications | 2 | 2019 | 32 | 0.300 |
Why?
|
Arousal | 1 | 2008 | 50 | 0.300 |
Why?
|
Cognition | 4 | 2021 | 1360 | 0.290 |
Why?
|
Delirium | 1 | 2007 | 13 | 0.280 |
Why?
|
Hospitalization | 2 | 2020 | 322 | 0.280 |
Why?
|
Aphasia, Primary Progressive | 1 | 2006 | 2 | 0.280 |
Why?
|
Attention Deficit and Disruptive Behavior Disorders | 2 | 2006 | 5 | 0.280 |
Why?
|
Obsessive-Compulsive Disorder | 1 | 2006 | 19 | 0.270 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2006 | 28 | 0.270 |
Why?
|
Psychopathology | 1 | 2006 | 6 | 0.270 |
Why?
|
Self Disclosure | 1 | 2006 | 7 | 0.270 |
Why?
|
Prevalence | 7 | 2014 | 476 | 0.270 |
Why?
|
Comorbidity | 4 | 2020 | 502 | 0.270 |
Why?
|
Social Problems | 2 | 2023 | 8 | 0.270 |
Why?
|
Transaminases | 1 | 2005 | 7 | 0.260 |
Why?
|
Simvastatin | 1 | 2005 | 14 | 0.250 |
Why?
|
Rhabdomyolysis | 1 | 2005 | 7 | 0.250 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2005 | 28 | 0.250 |
Why?
|
Triazoles | 1 | 2005 | 29 | 0.250 |
Why?
|
Hypolipidemic Agents | 1 | 2005 | 28 | 0.250 |
Why?
|
Antidepressive Agents | 1 | 2005 | 98 | 0.250 |
Why?
|
Prejudice | 2 | 2003 | 35 | 0.240 |
Why?
|
Cross-Sectional Studies | 6 | 2022 | 940 | 0.240 |
Why?
|
California | 3 | 2010 | 32 | 0.230 |
Why?
|
Education, Medical, Undergraduate | 1 | 2004 | 33 | 0.230 |
Why?
|
Algorithms | 1 | 2007 | 378 | 0.230 |
Why?
|
Education, Medical | 1 | 2004 | 41 | 0.230 |
Why?
|
Sex Factors | 5 | 2020 | 480 | 0.230 |
Why?
|
Pediatrics | 2 | 2020 | 46 | 0.220 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2020 | 22 | 0.220 |
Why?
|
Students | 1 | 2024 | 52 | 0.210 |
Why?
|
Mentors | 1 | 2023 | 43 | 0.210 |
Why?
|
Self Efficacy | 1 | 2023 | 60 | 0.210 |
Why?
|
Learning | 1 | 2023 | 71 | 0.200 |
Why?
|
Tertiary Care Centers | 2 | 2019 | 67 | 0.200 |
Why?
|
Mental Processes | 1 | 2022 | 20 | 0.200 |
Why?
|
Yoga | 2 | 2020 | 12 | 0.200 |
Why?
|
Education, Continuing | 1 | 2022 | 13 | 0.190 |
Why?
|
Artificial Intelligence | 1 | 2022 | 32 | 0.190 |
Why?
|
Psychotherapy, Group | 2 | 2019 | 43 | 0.190 |
Why?
|
Hospital Mortality | 1 | 2022 | 147 | 0.190 |
Why?
|
Internship and Residency | 2 | 2018 | 215 | 0.190 |
Why?
|
Prognosis | 2 | 2019 | 826 | 0.190 |
Why?
|
Mindfulness | 2 | 2020 | 48 | 0.190 |
Why?
|
Alcohol Drinking | 1 | 2021 | 81 | 0.180 |
Why?
|
Endpoint Determination | 1 | 2021 | 22 | 0.180 |
Why?
|
Dementia | 1 | 2006 | 578 | 0.180 |
Why?
|
Data Collection | 1 | 2021 | 98 | 0.180 |
Why?
|
Patients | 1 | 2021 | 35 | 0.180 |
Why?
|
Psychotherapy | 1 | 2021 | 43 | 0.180 |
Why?
|
Ethanol | 1 | 2021 | 120 | 0.180 |
Why?
|
Communication | 1 | 2001 | 124 | 0.180 |
Why?
|
Anxiety | 1 | 2021 | 160 | 0.170 |
Why?
|
Forecasting | 1 | 2020 | 102 | 0.170 |
Why?
|
Psychotherapy, Brief | 1 | 2020 | 3 | 0.170 |
Why?
|
Hospitals | 1 | 2021 | 154 | 0.170 |
Why?
|
Homosexuality, Male | 1 | 2020 | 26 | 0.170 |
Why?
|
Social Adjustment | 2 | 2017 | 28 | 0.170 |
Why?
|
Supervised Machine Learning | 1 | 2019 | 15 | 0.170 |
Why?
|
Insurance Coverage | 1 | 2019 | 16 | 0.170 |
Why?
|
Proportional Hazards Models | 1 | 2020 | 354 | 0.160 |
Why?
|
Precision Medicine | 1 | 2019 | 29 | 0.160 |
Why?
|
Suicide, Attempted | 1 | 2019 | 16 | 0.160 |
Why?
|
Trauma Centers | 1 | 2019 | 9 | 0.160 |
Why?
|
Global Health | 1 | 2019 | 42 | 0.160 |
Why?
|
HIV | 1 | 2019 | 43 | 0.160 |
Why?
|
Models, Theoretical | 1 | 2019 | 82 | 0.160 |
Why?
|
Physician-Patient Relations | 2 | 2013 | 43 | 0.160 |
Why?
|
Wounds and Injuries | 1 | 2019 | 45 | 0.150 |
Why?
|
Behavioral Symptoms | 1 | 2018 | 15 | 0.150 |
Why?
|
Hydrocortisone | 1 | 2018 | 40 | 0.150 |
Why?
|
Personality Inventory | 2 | 2009 | 76 | 0.150 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2020 | 108 | 0.150 |
Why?
|
Conduct Disorder | 2 | 2009 | 3 | 0.150 |
Why?
|
Occupational Diseases | 1 | 2018 | 22 | 0.150 |
Why?
|
Fellowships and Scholarships | 1 | 2018 | 42 | 0.150 |
Why?
|
Survivors | 1 | 2018 | 72 | 0.150 |
Why?
|
Infant | 1 | 2019 | 591 | 0.140 |
Why?
|
Iatrogenic Disease | 1 | 2017 | 28 | 0.140 |
Why?
|
Minors | 2 | 2014 | 5 | 0.140 |
Why?
|
Brain | 1 | 2006 | 1697 | 0.140 |
Why?
|
Risk | 1 | 2017 | 209 | 0.140 |
Why?
|
Thromboembolism | 1 | 2017 | 17 | 0.140 |
Why?
|
Risk Factors | 5 | 2021 | 2414 | 0.140 |
Why?
|
Catheterization, Central Venous | 1 | 2017 | 35 | 0.130 |
Why?
|
Parents | 1 | 2018 | 126 | 0.130 |
Why?
|
Thrombosis | 1 | 2017 | 57 | 0.130 |
Why?
|
Psychiatric Nursing | 1 | 2018 | 130 | 0.130 |
Why?
|
Heart Diseases | 1 | 2017 | 68 | 0.130 |
Why?
|
Resilience, Psychological | 2 | 2014 | 28 | 0.130 |
Why?
|
Interviews as Topic | 1 | 2015 | 137 | 0.120 |
Why?
|
Risk Assessment | 2 | 2020 | 674 | 0.120 |
Why?
|
Escape Reaction | 1 | 2014 | 1 | 0.110 |
Why?
|
Feeding and Eating Disorders | 1 | 2014 | 12 | 0.110 |
Why?
|
Interpersonal Relations | 2 | 2012 | 104 | 0.110 |
Why?
|
Personality Disorders | 1 | 2013 | 17 | 0.110 |
Why?
|
United Kingdom | 2 | 2004 | 54 | 0.110 |
Why?
|
Psychology, Military | 1 | 2013 | 1 | 0.110 |
Why?
|
Age Factors | 2 | 2020 | 796 | 0.110 |
Why?
|
Repression, Psychology | 1 | 2013 | 3 | 0.110 |
Why?
|
Physicians, Primary Care | 1 | 2013 | 7 | 0.110 |
Why?
|
Physician's Role | 1 | 2013 | 19 | 0.110 |
Why?
|
Medical History Taking | 1 | 2013 | 30 | 0.100 |
Why?
|
Mental Status Schedule | 1 | 2013 | 98 | 0.100 |
Why?
|
Aged, 80 and over | 2 | 2019 | 4881 | 0.100 |
Why?
|
Acrosome | 1 | 1992 | 1 | 0.100 |
Why?
|
Spermatocytes | 1 | 1992 | 1 | 0.100 |
Why?
|
GTP-Binding Proteins | 1 | 1992 | 13 | 0.100 |
Why?
|
Mass Behavior | 1 | 2012 | 1 | 0.100 |
Why?
|
Social Change | 1 | 2012 | 4 | 0.100 |
Why?
|
Personality | 1 | 2013 | 56 | 0.100 |
Why?
|
Physical Examination | 1 | 2013 | 119 | 0.100 |
Why?
|
Severity of Illness Index | 3 | 2021 | 993 | 0.100 |
Why?
|
Neuropsychological Tests | 2 | 2006 | 1257 | 0.100 |
Why?
|
Animals | 2 | 2017 | 3808 | 0.090 |
Why?
|
Cross-Cultural Comparison | 1 | 2011 | 39 | 0.090 |
Why?
|
Psychology | 1 | 2011 | 24 | 0.090 |
Why?
|
Competency-Based Education | 1 | 2010 | 16 | 0.090 |
Why?
|
Drug Resistance | 1 | 2009 | 47 | 0.080 |
Why?
|
Interview, Psychological | 1 | 2009 | 42 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2009 | 184 | 0.080 |
Why?
|
Child, Abandoned | 1 | 2009 | 2 | 0.080 |
Why?
|
Cohort Studies | 2 | 2019 | 1936 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2019 | 234 | 0.080 |
Why?
|
Free Association | 1 | 2008 | 1 | 0.080 |
Why?
|
Austria | 3 | 2014 | 6 | 0.080 |
Why?
|
Qualitative Research | 2 | 2019 | 121 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 326 | 0.070 |
Why?
|
Heart Rate | 1 | 2008 | 115 | 0.070 |
Why?
|
Encephalitis, Herpes Simplex | 1 | 2007 | 1 | 0.070 |
Why?
|
Psychoses, Substance-Induced | 1 | 2007 | 4 | 0.070 |
Why?
|
Risperidone | 1 | 2007 | 4 | 0.070 |
Why?
|
Haloperidol | 1 | 2007 | 6 | 0.070 |
Why?
|
Hyperkinesis | 1 | 2007 | 8 | 0.070 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2007 | 13 | 0.070 |
Why?
|
Mood Disorders | 1 | 2007 | 29 | 0.070 |
Why?
|
Electroshock | 1 | 2006 | 1 | 0.070 |
Why?
|
Inclusion Bodies | 1 | 2006 | 13 | 0.070 |
Why?
|
Fatal Outcome | 1 | 2006 | 58 | 0.070 |
Why?
|
Tauopathies | 1 | 2006 | 21 | 0.070 |
Why?
|
Puberty, Precocious | 1 | 2006 | 1 | 0.070 |
Why?
|
Diagnostic Errors | 1 | 2006 | 31 | 0.070 |
Why?
|
Atrophy | 1 | 2006 | 91 | 0.070 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2007 | 350 | 0.070 |
Why?
|
Psychopharmacology | 1 | 2006 | 2 | 0.070 |
Why?
|
Logistic Models | 2 | 2020 | 399 | 0.070 |
Why?
|
Drug Interactions | 1 | 2005 | 38 | 0.060 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2006 | 80 | 0.060 |
Why?
|
Hyperlipidemias | 1 | 2005 | 18 | 0.060 |
Why?
|
Diagnosis, Differential | 1 | 2006 | 371 | 0.060 |
Why?
|
Adaptation, Psychological | 2 | 2019 | 180 | 0.060 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2007 | 244 | 0.060 |
Why?
|
Multivariate Analysis | 2 | 2018 | 334 | 0.060 |
Why?
|
Piperazines | 1 | 2005 | 80 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2005 | 103 | 0.060 |
Why?
|
Chi-Square Distribution | 1 | 2004 | 146 | 0.060 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2007 | 192 | 0.060 |
Why?
|
Disease Progression | 1 | 2006 | 721 | 0.060 |
Why?
|
Illinois | 1 | 2004 | 247 | 0.060 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2017 | 329 | 0.050 |
Why?
|
Health Care Surveys | 1 | 2003 | 66 | 0.050 |
Why?
|
Life Change Events | 2 | 2014 | 38 | 0.050 |
Why?
|
Africa | 2 | 2014 | 11 | 0.050 |
Why?
|
Warfare | 2 | 2014 | 14 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2006 | 611 | 0.050 |
Why?
|
Parenting | 2 | 2018 | 81 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 1 | 2006 | 772 | 0.050 |
Why?
|
State Medicine | 1 | 2001 | 3 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 1 | 2006 | 1197 | 0.050 |
Why?
|
Unified Medical Language System | 1 | 2020 | 1 | 0.040 |
Why?
|
Marijuana Abuse | 1 | 2020 | 6 | 0.040 |
Why?
|
Tobacco Use | 1 | 2020 | 8 | 0.040 |
Why?
|
Medical Records | 1 | 2020 | 34 | 0.040 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 8 | 0.040 |
Why?
|
Text Messaging | 1 | 2019 | 16 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2020 | 137 | 0.040 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 312 | 0.040 |
Why?
|
Psychological Techniques | 1 | 2018 | 1 | 0.040 |
Why?
|
Population | 1 | 2018 | 5 | 0.040 |
Why?
|
Quality of Health Care | 1 | 2020 | 126 | 0.040 |
Why?
|
ROC Curve | 1 | 2019 | 145 | 0.040 |
Why?
|
Psychometrics | 1 | 2019 | 244 | 0.040 |
Why?
|
Parent-Child Relations | 1 | 2018 | 40 | 0.040 |
Why?
|
Afghan Campaign 2001- | 1 | 2017 | 6 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 519 | 0.040 |
Why?
|
Iraq War, 2003-2011 | 1 | 2017 | 8 | 0.040 |
Why?
|
Health Promotion | 1 | 2019 | 161 | 0.040 |
Why?
|
Pilot Projects | 1 | 2019 | 441 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2019 | 604 | 0.040 |
Why?
|
Checklist | 1 | 2017 | 40 | 0.040 |
Why?
|
Central Venous Catheters | 1 | 2017 | 2 | 0.030 |
Why?
|
Reproducibility of Results | 1 | 2019 | 727 | 0.030 |
Why?
|
India | 1 | 2017 | 22 | 0.030 |
Why?
|
Focus Groups | 1 | 2017 | 93 | 0.030 |
Why?
|
Research | 1 | 2016 | 43 | 0.030 |
Why?
|
Mothers | 1 | 2018 | 193 | 0.030 |
Why?
|
Methylphenidate | 1 | 2016 | 8 | 0.030 |
Why?
|
Clinical Decision-Making | 1 | 2016 | 42 | 0.030 |
Why?
|
Autopsy | 1 | 2017 | 347 | 0.030 |
Why?
|
Practice Patterns, Physicians' | 1 | 2016 | 122 | 0.030 |
Why?
|
Age Distribution | 1 | 2014 | 90 | 0.030 |
Why?
|
Family Relations | 1 | 2014 | 14 | 0.030 |
Why?
|
Sex Distribution | 1 | 2014 | 82 | 0.030 |
Why?
|
Virulence Factors, Bordetella | 1 | 1992 | 2 | 0.030 |
Why?
|
Pertussis Toxin | 1 | 1992 | 3 | 0.030 |
Why?
|
Spermatids | 1 | 1992 | 2 | 0.030 |
Why?
|
Macromolecular Substances | 1 | 1992 | 6 | 0.030 |
Why?
|
Cell Compartmentation | 1 | 1992 | 8 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 1992 | 30 | 0.030 |
Why?
|
Antibodies | 1 | 1992 | 49 | 0.030 |
Why?
|
Self Report | 1 | 2013 | 226 | 0.020 |
Why?
|
Yugoslavia | 1 | 2011 | 2 | 0.020 |
Why?
|
Turkey | 1 | 2011 | 6 | 0.020 |
Why?
|
Family Characteristics | 1 | 2011 | 21 | 0.020 |
Why?
|
Motivation | 1 | 2011 | 99 | 0.020 |
Why?
|
Child Welfare | 1 | 2009 | 20 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2014 | 1870 | 0.020 |
Why?
|
Mice | 1 | 1992 | 1475 | 0.020 |
Why?
|
Child Abuse, Sexual | 1 | 2006 | 11 | 0.020 |
Why?
|
Drug Compounding | 1 | 2005 | 3 | 0.020 |
Why?
|
Expert Testimony | 1 | 2005 | 14 | 0.020 |
Why?
|
Autistic Disorder | 1 | 2005 | 40 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2005 | 109 | 0.010 |
Why?
|